Worta McCaskill-Stevens
Born(1949-07-26)July 26, 1949
Louisburg, North Carolina, U.S.
DiedNovember 15, 2023(2023-11-15) (aged 74)
Alma mater
Scientific career
FieldsMedical oncology, clinical trials
InstitutionsNational Cancer Institute

Worta J. McCaskill-Stevens (July 26, 1949 – November 15, 2023) was an American physician-scientist and medical oncologist specialized in cancer disparities research, management of comorbidities within clinical trials, and molecular research for cancer prevention interventions. She was chief of the community oncology and prevention trials research group at the National Cancer Institute.

Early life and education

McCaskill-Stevens was born in Louisburg, North Carolina on July 26, 1949.[1][2] She attended Washington University in St. Louis and the American College of Switzerland.[3] McCaskill-Stevens worked as an intern for Time and as a medical editor for Marcel Dekker and the Guttmacher Institute.[4] At Georgetown University School of Medicine, she started medical school at age 30, earning a M.D. in 1985 and completing an internal medicine residency. McCaskill-Stevens did a medical oncology fellowship at the Mayo Clinic.[3][4]

Career and research

McCaskill-Stevens at the National Cancer Institute pre-2013

McCaskill-Stevens, a medical oncologist, joined the National Cancer Institute (NCI) in 1998 as the program director for the study of tamoxifen and raloxifene (STAR), and assumed responsibilities for breast cancer prevention with the community clinical oncology program (CCOP). She chaired the 2009 National Institutes of Health (NIH) State-of-the Science Conference on ductal carcinoma in situ; was a member of the early breast cancer clinical trialist group in Oxford; and was a member of NCI's breast cancer steering committee. McCaskill-Stevens co-directed the breast care and research center at the Indiana University Cancer Center.[3]

McCaskill-Stevens was chief of the community oncology and prevention trials research group, which houses the NCI community oncology research program (NCORP), a community-based clinical trials network launched in 2014. As NCORP director, she oversaw the program supporting community hospitals, physicians and others to participate in NCI-approved cancer treatment, prevention, screening, and control clinical trials, as well as cancer care delivery studies.[3]

McCaskill-Stevens' interests included cancer disparities research both nationally and internationally, management of comorbidities within clinical trials and molecular research that helps to identify those individuals who will best benefit from cancer prevention interventions.[3] She worked with the Study of Tamoxifen and Raloxifene (STAR), as the program director.[5]

Awards and honors

In 2016, she was the recipient of the American Association for Cancer Research Jane Cooke Wright Memorial Lectureship. Her other honors and awards include: the Kaiser Family Fund Award for Excellence in Academic Achievement and Leadership in Medicine; Omega Alpha Medical Honor Society; the NIH Director's Award for Clinical Trials; the NCI Merit Award for breast cancer prevention; and listed on Ebony's 2013 Power 100 – Most Influential African Americans in Science and Health.[3] In 2017, she received an honorary Doctor of Science from her alma mater, Georgetown University.[4] McCaskill-Stevens was the recipient of the 2020 ACCC David King Community Clinical Scientist Award, from the Association of Community Cancer Centers (ACCC).[6] Winners of the prestigious David King Award have "demonstrated leadership in the development, participation, and evaluation of clinical studies and/or are active in the development of new screening, risk assessment, treatment, or supportive care programs for cancer patients."[7]

Personal life

McCaskill-Stevens died on November 15, 2023.[8]

References

  1. ↑ "IN MEMORIAM: WORTA MCCASKILL-STEVENS". American Association for Cancer Research. Retrieved November 22, 2023.
  2. ↑ "Worta McCaskill-Stevens | Office of Equity, Diversity and Inclusion". www.edi.nih.gov. Retrieved January 2, 2021.Public Domain This article incorporates text from this source, which is in the public domain.
  3. 1 2 3 4 5 6 "Worta McCaskill-Stevens, M.D., M.S." Division of Cancer Prevention. August 13, 2014. Retrieved January 2, 2021.Public Domain This article incorporates text from this source, which is in the public domain.
  4. 1 2 3 Twombly, Renee (May 8, 2017). "McCaskill-Stevens to Address Graduates at School of Medicine Commencement". Georgetown University Medical Center. Retrieved January 2, 2021.
  5. ↑ "Worta McCaskill-Stevens | Office of Equity, Diversity and Inclusion". www.edi.nih.gov. Retrieved February 22, 2022.
  6. ↑ "Worta McCaskill-Stevens, MD, MS, Named 2020 ACCC David King Community Clinical Scientist Award Winner" (Press release). Association of Community Cancer Centers. December 14, 2020. Retrieved November 20, 2023.
  7. ↑ "David King Community Clinical Scientist Award". Association of Community Cancer Centers. Retrieved November 20, 2023.
  8. ↑ Akshay (November 16, 2023). "Statement on the passing of Dr. Worta McCaskill-Stevens". ECOG-ACRIN Cancer Research Group. Retrieved November 17, 2023.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.